<DOC>
	<DOCNO>NCT02121171</DOCNO>
	<brief_summary>The objective prospective randomise study compare efficacy safety ologen CM ( Collagen matrix ) adjunct combine trabeculotomy-trabecuectomy congenital glaucoma case , efficacy primary objective safety secondary . The investigator hypothesize combine trabeculotomy-trabecuectomy Ologen collagen matrix implant implantation congenital glaucoma safer procedure may yield good result combine trabeculotomy-trabeculectomy approach .</brief_summary>
	<brief_title>Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation Ologen Primary Congenital Glaucoma</brief_title>
	<detailed_description>`` Ologen Â® CM '' biodegradable collagen matrix . To prevent episcleral fibrosis subconjunctival scar thay may result surgical failure filtration surgery , sporous matrix modulates migration proliferation fibroblast create vascular long-lasting bleb without adverse effect . Results ologen CM study publish conference publish peer-reviewed journal ; ologen CM approve Europe aid tissue repair , FDA US adjunct wound management ( K080868 ) . In general , 7,000 ologen CM implant worldwide past two year good result excellent safety profile .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Hydrophthalmos</mesh_term>
	<criteria>Any case diagnose congenital glaucoma enlarge corneal diameter 11 mm intraocular pressure 21 mmHg , include corneal edema Haab 's stria without optic disc cup . Any case diagnose primary secondary congenital glaucoma ocular systemic abnormality . Within age ( 0 12 ) . Cases congenital glaucoma previous intervention . Age 12 Yrs . Cases secondary glaucoma cause surgical intervention , ocular comorbidity , medication trauma</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>